ES2301807T3 - Compuestos de amoniociclodextrina cuaternizados. - Google Patents

Compuestos de amoniociclodextrina cuaternizados. Download PDF

Info

Publication number
ES2301807T3
ES2301807T3 ES03740232T ES03740232T ES2301807T3 ES 2301807 T3 ES2301807 T3 ES 2301807T3 ES 03740232 T ES03740232 T ES 03740232T ES 03740232 T ES03740232 T ES 03740232T ES 2301807 T3 ES2301807 T3 ES 2301807T3
Authority
ES
Spain
Prior art keywords
formula
chosen
compounds
drugs
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03740232T
Other languages
English (en)
Spanish (es)
Inventor
Georg Ludwig Kis
Christian Schoch
Jozsef Szejtli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2301807T3 publication Critical patent/ES2301807T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES03740232T 2002-06-13 2003-06-12 Compuestos de amoniociclodextrina cuaternizados. Expired - Lifetime ES2301807T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02013074 2002-06-13
EP02013074 2002-06-13
EP02028554 2002-12-20
EP02028554 2002-12-20

Publications (1)

Publication Number Publication Date
ES2301807T3 true ES2301807T3 (es) 2008-07-01

Family

ID=29737927

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03740232T Expired - Lifetime ES2301807T3 (es) 2002-06-13 2003-06-12 Compuestos de amoniociclodextrina cuaternizados.

Country Status (15)

Country Link
US (4) US20050222085A1 (zh)
EP (1) EP1515729B1 (zh)
JP (2) JP4773721B2 (zh)
CN (1) CN100589809C (zh)
AT (1) ATE386532T1 (zh)
AU (1) AU2003276957A1 (zh)
BR (1) BR0311722A (zh)
CA (1) CA2487332C (zh)
CY (1) CY1108099T1 (zh)
DE (1) DE60319221T2 (zh)
DK (1) DK1515729T3 (zh)
ES (1) ES2301807T3 (zh)
PT (1) PT1515729E (zh)
SI (1) SI1515729T1 (zh)
WO (1) WO2003105867A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100678824B1 (ko) * 2005-02-04 2007-02-05 한미약품 주식회사 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물
KR20160033796A (ko) 2006-03-28 2016-03-28 자블린 파머슈티칼스 인코포레이티드 저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
CN101757621B (zh) * 2008-11-28 2012-07-04 天津金耀集团有限公司 一种眼部抗炎的环糊精包合药物组合物
US9642920B2 (en) * 2009-06-03 2017-05-09 Case Western Reserve University Therapeutic agent delivery system and method
CN102276761A (zh) * 2010-06-11 2011-12-14 南京理工大学 单取代铵基正电型-β-环糊精及其制备方法
GB201114459D0 (en) * 2011-08-22 2011-10-05 Isis Innovation Anti-bacterial compounds
CN103497275B (zh) * 2013-08-09 2015-12-23 华北电力大学（保定） 一种抗菌、抗病毒胍盐星形聚合物及其制备方法和应用
CZ307458B6 (cs) * 2014-11-25 2018-09-12 Spur A.S. Vícevrstvý kryt rány s aktivní vrstvou a způsob jeho výroby
EP3227379B1 (en) * 2014-12-02 2020-07-29 B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University Quaternized starches for use as anti-microbial agents
CN109487588B (zh) * 2018-11-19 2021-04-20 绍兴永通印花有限公司 一种印花用涤纶织物处理液及其使用方法
CN114015127B (zh) 2019-02-14 2022-07-19 赛克洛珀股份有限公司 带有电荷的环糊精聚合物材料以及其制造和使用方法
CN109836512A (zh) * 2019-03-04 2019-06-04 西南石油大学 一种新型β-CD双子表面活性剂为稠化剂的清洁压裂液
CN112386710A (zh) * 2020-12-09 2021-02-23 星拜(苏州)生物科技有限公司 一种利用包埋技术改善紫檀芪水溶性的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453257A (en) * 1967-02-13 1969-07-01 Corn Products Co Cyclodextrin with cationic properties
JPS58210901A (ja) * 1982-06-01 1983-12-08 Kao Corp シクロデキストリン誘導体およびその製造方法
IT1229133B (it) * 1989-03-09 1991-07-22 Farmhispania Sali ammonici di policiclodestrine per l'impiego come agenti ipocolesterolemizzanti
JPH0481401A (ja) * 1990-07-24 1992-03-16 Toppan Printing Co Ltd シクロデキストリン誘導体
DE69127256T2 (de) * 1990-05-21 1998-02-12 Toppan Printing Co Ltd Cyclodextrinderivat
JPH0665307A (ja) * 1992-06-17 1994-03-08 Sankyo Co Ltd シクロデキストリン誘導体
CA2201134A1 (en) * 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
AU759280C (en) * 1998-02-23 2004-01-22 Cyclops, Ehf High-energy cyclodextrin complexes

Also Published As

Publication number Publication date
SI1515729T1 (sl) 2008-08-31
DK1515729T3 (da) 2008-06-16
EP1515729A1 (en) 2005-03-23
DE60319221T2 (de) 2009-03-05
JP2011006448A (ja) 2011-01-13
BR0311722A (pt) 2005-03-01
JP4773721B2 (ja) 2011-09-14
CA2487332A1 (en) 2003-12-24
CY1108099T1 (el) 2014-02-12
AU2003276957A1 (en) 2003-12-31
WO2003105867A1 (en) 2003-12-24
CN100589809C (zh) 2010-02-17
US20090110734A1 (en) 2009-04-30
DE60319221D1 (de) 2008-04-03
US20130137657A1 (en) 2013-05-30
US20050222085A1 (en) 2005-10-06
PT1515729E (pt) 2008-05-30
EP1515729B1 (en) 2008-02-20
JP2005529175A (ja) 2005-09-29
CN1658888A (zh) 2005-08-24
CA2487332C (en) 2012-05-15
ATE386532T1 (de) 2008-03-15
US20120004158A1 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
US20090110734A1 (en) Quaternised ammonium cyclodextrin compounds
ES2237836T3 (es) Liberacion controlada de productos farmaceuticos en la camara anterior del ojo.
ES2461617T3 (es) Composiciones farmacéuticas acuosas que contienen complejos borato-polioles
CA2764481C (en) Pharmaceutical composition for use in medical and veterinary ophthalmology
ES2326471T3 (es) Composicion de uso topico que comprende un ciclofructano, un vehiculo y un farmaco.
ES2316867T3 (es) Uso de rimexolona en el tratamiento del ojo seco.
ES2644550T3 (es) Composiciones farmacéuticas acuosas que contienen complejos de borato-poliol
EP0785780A1 (en) Ophthalmic and aural compositions containing diclofenac potassium
WO2011018800A2 (en) A novel in-situ gel forming solution for ocular drug delivery
ES2199348T3 (es) Uso de inhibidores de carbonico anhidrasa para el tratamiento del edema macular.
ES2941036T3 (es) Composición tópica oftálmica que comprende ácido dobesílico para el tratamiento de enfermedades del segmento posterior del ojo
ES2796361T3 (es) Uso terapéutico de una solución oftálmica acuosa estéril
ES2895923T3 (es) Composición para prevención/tratamiento de daño corneal que comprende timosina beta 4 y ácido cítrico como ingredientes activos
ES2773537T3 (es) Uso terapéutico de una solución oftálmica acuosa estéril
US20210369648A1 (en) Cysteamine zinc complex and method of using a cysteamine zinc complex
ES2974884T3 (es) Composición de colirio para reducir la presión intraocular
US20190216778A1 (en) Pyrrolidone carboxylic acid (pca) for ophthalmic use
PT1927353E (pt) Medicamento para doenças corneais